📄 Extracted Text (575 words)
To: James Meiskini
From:
Sent Wed 5/21/2014 10:25:53 PM
Subject Re: Confidential
Fabulous!!
Sent from my iPhone
On May 21, 2014, at 6:05 PM, James Meiskin Wrote:
Confirmed. Thank you Lesley.
Sent from my iPhone
On May 21, 2014, at 5:51 PM, wrote:
Jeffrey's home, 9 East 71st Street between 5th and Madison... 5pm
would be great.
On May 21, 2014, at 5:14 PM, James Meiskin
wrote:
That will work. Do you have a time and location in
mind? Thank you, James
Sent from my iPhone
On May 21, 2014, at 10:25 AM,
wrote:
Great. Would Sunday June 1st work?
Sent from my iPhone
On May 21, 2014, at 9:47 AM, James Meiskin
wrote:
Of course. Please get me dates
that work for Jeffrey, and I will
have David fly in from CA to
meet him with pleasure.
Hope your well
EFTA_R1_00718269
EFTA02104933
Best, James
Sent from my iPhone
On May 21, 2014, at 9:41 AM,
wrote:
HI James....below
is Jeffrey's
response:
im not in ny until
june but happy to
see you both after
Might it be possible to schedule something the beginning
of June?
On May 21, 2014, at 9:23 AM, "James Meiskin"
Jeffrey
, David
Carter
(Comp
any
inform
ation is
attach
ed), is
in NY
today
and
tomorr
ow
momin
g, and
I felt
that it
could
be
benefi
cial
EFTA_R1_00718270
EFTA02104934
and
timely
for you
to
further
learn
about
this
opport
unity if
there
was
interes
ton
your
end.
Please
take a
mome
nt to
review
the
attach
ed
materi
al. and
let me
know if
you
would
like to
meet
while
David
is in
NYC.
Best
Regar
ds,
James
Dear James,
like I have said in an earlier email. I am looking
for an "investing partner" to match (50%/50%)
the money Russian Venture Capital plans to
invest in USA based Biotechnology. They will
provide half of the capital to develop a variety of
EFTA_R1_00718271
EFTA02104935
technologies that are of interest to their country.
For their investment they get commercialization
rights to the technologies they finance for Russia
and the CIS. For us, on the USA side, this is a
major source of capital to start a series of
companies that have great potential as
therapeutic technologies, and we get
commercialization rights for the USA, and rest of
the world markets. Basically, we get the rights
that are valuable to us at "half price".
Over the next several years our plan is to identify
seven/eight technologies that are worthy of
development. RVC has already agreed to finance
the first (MAJI) and is looking at the next
two—Prediction Biosciences, and OvationBio. I
have several more currently in diligence. (The
original Investor Presentation made in Moscow is
attached)
So, lam looking for a source of capital that thinks
this is an interesting investment theme, and is
willing to consider the idea as something they
might want to implement. My belief is that there
is more money in NYC, seeking an investment
home, then there are "quality investment
ideas". I could be wrong, but I have to believe
that people running a lot of capital in New York
would want to hear new, creative, and GOOD
new investment ideas. I think this idea is the
kind of idea that is worth a look, and worth
serious consideration. I think we are talking
$150M over a five year horizon.
Best, David
David W. Carter
President—DaCart Capital LLC
<DaC
art
Prese
ntatio
n.pptx
EFTA_R1_00718272
EFTA02104936
ℹ️ Document Details
SHA-256
1595b811ee14947fcf60a049e3c923ae2146425d12c0a56642e76918ca539b88
Bates Number
EFTA02104933
Dataset
DataSet-10
Document Type
document
Pages
4
Comments 0